Randomized clinical trial on the influence of anaesthesia protocol on intestinal motility during laparoscopic surgery requiring small bowel anastomosis

British Journal of Surgery

Volumn 99, Issue 11, 2012, Pages 1524-1529

  De Corte, W ^a   Delrue, H ^a   Vanfleteren, L J J ^a   Dutre P E M ^a   Pottel, H ^b   Devriendt, D K J C ^a   Van Rooy, F H E C ^a   D'Hondt, M ^a   Carlier, S ^a   Desmet, M B ^a  

^a Groeninge Hospital   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

DESFLURANE; DRUG DERIVATIVE; ETHER DERIVATIVE; INHALATION ANESTHETIC AGENT; ISOFLURANE; MUSCARINIC RECEPTOR BLOCKING AGENT; SCOPOLAMINE BROMIDE; SEVOFLURANE;

ADULT; ARTICLE; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; GASTROINTESTINAL MOTILITY; HUMAN; LAPAROSCOPY; MALE; METHODOLOGY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STOMACH BYPASS;

ADULT; ANESTHETICS, INHALATION; BODY MASS INDEX; DOUBLE-BLIND METHOD; FEMALE; GASTRIC BYPASS; GASTROINTESTINAL MOTILITY; HUMANS; ISOFLURANE; LAPAROSCOPY; MALE; METHYL ETHERS; MUSCARINIC ANTAGONISTS; PROSPECTIVE STUDIES; SCOPOLAMINE HYDROBROMIDE;

EID: 84867099670     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.8883     Document Type: Article

References (20)

1. Mokdad AH, Serdula MK, Dietz WH, Bowman BA, Marks JS, Koplan JP,. The spread of the obesity epidemic in the United States, 1991-1998. JAMA 1999; 282: 1519-1522.
2. Sugerman HJ, Kellum JM, Engle KM, Wolfe L, Starkey JV, Birkenhauer R, et al., Gastric bypass for treating severe obesity. Am J Clin Nutr 1992; 55 (Suppl): 560S-566S.
3. Kirkegaard-Nielsen H, Helbo-Hansen HS, Lindholm P, Severinsen IK, Pedersen HS,. Anthropometric variables as predictors for duration of action of atracurium-induced neuromuscular block. Anesth Analg 1996; 83: 1076-1080.
4. Graves DA, Batenhorst RL, Bennett RL, Wettstein JG, Griffen WO, Wright BD, et al., Morphine requirements using patient-controlled analgesia: influence of diurnal variation and morbid obesity. Clin Pharm 1983; 2: 49-53.
5. Strum EM, Szenohradszki J, Kaufman WA, Anthone GJ, Manz IL, Lumb PD,. Emergence and recovery characteristics of desflurane versus sevoflurane in morbidly obese adult surgical patients: a prospective, randomized study. Anesth Analg 2004; 99: 1848-1853.
6. McKay RE, Malhotra A, Cakmakkaya OS, Hall KT, McKay WR, Apfel CC,. Effect of increased body mass index and anaesthetic duration on recovery of protective airway reflexes after sevoflurane vs desflurane. Br J Anaesth 2010; 104: 175-182.
7. De Baerdemaeker LE, Jacobs S, Den Blauwen NM, Pattyn P, Herregods LL, Mortier EP, et al., Postoperative results after desflurane or sevoflurane combined with remifentanil in morbidly obese patients. Obes Surg 2006; 16: 728-733.
8. Vallejo MC, Sah N, Phelps AL, O'Donnell J, Romeo RC,. Desflurane versus sevoflurane for laparoscopic gastroplasty in morbidly obese patients. J Clin Anesth 2007; 19: 3-8.
9. Holzer P, Holzer-Petsche U,. Tachykinin receptors in the gut: physiological and pathological implications. Curr Opin Pharmacol 2001; 1: 583-590.
10. Holzer P, Holzer-Petsche U,. Tachykinins in the gut. Part I. Expression, release and motor function. Pharmacol Ther 1997; 73: 173-217.
11. Shimizu Y, Matsuyama H, Shiina T, Takewaki T, Furness JB,. Tachykinins and their functions in the gastrointestinal tract. Cell Mol Life Sci 2008; 65: 295-311.
12. Satoh JI, Yamakage M, Kobayashi T, Tohse N, Watanabe H, Namiki A,. Desflurane but not sevoflurane can increase lung resistance via tachykinin pathways. Br J Anaesth 2009; 102: 704-713.
13. Eilers H, Cattaruzza F, Nassini R, Materazzi S, Andre E, Chu C, et al., Pungent general anesthetics activate transient receptor potential-A1 to produce hyperalgesia and neurogenic bronchoconstriction. Anesthesiology 2010; 112: 1452-1463.
14. Nozawa K, Kawabata-Shoda E, Doihara H, Kojima R, Okada H, Mochizuki S, et al., TRPA1 regulates gastrointestinal motility through serotonin release from enterochromaffin cells. Proc Natl Acad Sci U S A 2009; 106: 3408-3413.
15. Penuelas A, Tashima K, Tsuchiya S, Matsumoto K, Nakamura T, Horie S, et al., Contractile effect of TRPA1 receptor agonists in the isolated mouse intestine. Eur J Pharmacol 2007; 576: 143-150.
16. Moran MM, McAlexander MA, Biro T, Szallasi A,. Transient receptor potential channels as therapeutic targets. Nat Rev Drug Discov 2011; 10: 601-620.
17. Kaki AM, Almarakbi WA,. Does patient position influence the reading of the bispectral index monitor? Anesth Analg 2009; 109: 1843-1846.
18. Avidan MS, Zhang L, Burnside BA, Finkel KJ, Searleman AC, Selvidge JA, et al., Anesthesia awareness and the bispectral index. N Engl J Med 2008; 358: 1097-1108.
19. Dahaba AA,. Different conditions that could result in the bispectral index indicating an incorrect hypnotic state. Anesth Analg 2005; 101: 765-773.
20. Bruhn J, Kreuer S, Bischoff P, Kessler P, Schmidt GN, Grzesiak A, et al., Bispectral index and A-line AAI index as guidance for desflurane-remifentanil anaesthesia compared with a standard practice group: a multicentre study. Br J Anaesth 2005; 94: 63-69.